KR880002822A - 뇌허혈증 예방 치료제 - Google Patents

뇌허혈증 예방 치료제 Download PDF

Info

Publication number
KR880002822A
KR880002822A KR870009041A KR870009041A KR880002822A KR 880002822 A KR880002822 A KR 880002822A KR 870009041 A KR870009041 A KR 870009041A KR 870009041 A KR870009041 A KR 870009041A KR 880002822 A KR880002822 A KR 880002822A
Authority
KR
South Korea
Prior art keywords
cerebral ischemia
alkyl group
prevention treatment
ischemia prevention
agent
Prior art date
Application number
KR870009041A
Other languages
English (en)
Inventor
미노루 야마모또
노부오 사까모또
요시노부 나가노
Original Assignee
모리오까 시게오
야마노우찌 세이야꾸 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 모리오까 시게오, 야마노우찌 세이야꾸 가부시끼 가이샤 filed Critical 모리오까 시게오
Publication of KR880002822A publication Critical patent/KR880002822A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/063Glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

뇌허혈증 예방 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 유효 성분으로서, 다음 일반식(Ⅰ)의 글루타티온 모노알킬 에스테르 또는 그의 염을 함유하는 뇌허혈중 예방 치료제:
    상기식에서, R은 알킬 그룹을 나타낸다.
  2. 제1항에 있어서, R이 저급 알킬 그룹인 뇌허혈증 예방 치료제.
  3. 제2항에 있어서, R이 이소프로필 그룹인 뇌허혈증 예방 치료제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR870009041A 1986-08-20 1987-08-19 뇌허혈증 예방 치료제 KR880002822A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP196006 1986-08-20
JP19600686 1986-08-20

Publications (1)

Publication Number Publication Date
KR880002822A true KR880002822A (ko) 1988-05-11

Family

ID=16350660

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870009041A KR880002822A (ko) 1986-08-20 1987-08-19 뇌허혈증 예방 치료제

Country Status (5)

Country Link
EP (1) EP0257992B1 (ko)
JP (1) JPS63152325A (ko)
KR (1) KR880002822A (ko)
AT (1) ATE79268T1 (ko)
DE (1) DE3781064T2 (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968671A (en) * 1987-11-26 1990-11-06 Yamanouchi Pharmaceutical Co., Ltd. Therapeutic agents for ischemic heart diseases
US5093478A (en) * 1989-07-14 1992-03-03 Cornell Research Foundation, Inc. Preparing glutathione monoesters
ES2092539T3 (es) * 1991-01-10 1996-12-01 Transcend Therapeutics Inc Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares.
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5095027A (en) * 1991-02-28 1992-03-10 Clintec Nutrition Co. Method for treating reperfusion injury employing L-2-oxothiazolidine-4-carboxylic acid
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
JPH08509737A (ja) * 1993-05-03 1996-10-15 コーネル・リサーチ・ファウンデーション・インコーポレイテッド グルタチオンジエステルの使用
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
US20060105972A1 (en) 2004-11-17 2006-05-18 Nagasawa Herbert T Method to enhance delivery of glutathione and ATP levels in cells
TW201201712A (en) 2010-01-28 2012-01-16 Max International Llc Compositions comprising sugar-cysteine products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58215188A (ja) * 1982-06-07 1983-12-14 Nippon Telegr & Teleph Corp <Ntt> メモ記入・表示回路
JPS60165883A (ja) * 1984-02-09 1985-08-29 Matsushita Electric Ind Co Ltd テレビジヨン信号送受信方法およびテレビジヨン信号受信方法
JPS61179691A (ja) * 1985-02-05 1986-08-12 Matsushita Graphic Commun Syst Inc 画像会議システム
JPH0783471B2 (ja) * 1985-06-13 1995-09-06 株式会社東芝 画像通信ネツトワ−ク装置

Also Published As

Publication number Publication date
EP0257992B1 (en) 1992-08-12
DE3781064D1 (de) 1992-09-17
ATE79268T1 (de) 1992-08-15
EP0257992A2 (en) 1988-03-02
EP0257992A3 (en) 1989-10-25
JPS63152325A (ja) 1988-06-24
DE3781064T2 (de) 1992-12-17

Similar Documents

Publication Publication Date Title
KR890003720A (ko) 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
KR890007730A (ko) 허혈성 심질환 치료제
ES2095976T3 (es) Compuestos de pirazolopiridina y procedimiento para su preparacion.
KR930005972A (ko) N-알킬-3-페닐-3-(2-알킬티오페녹시)프로필아민
KR880002822A (ko) 뇌허혈증 예방 치료제
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
KR960007592A (ko) 신규한 피롤로카바졸
DK0630252T3 (da) Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme
KR910004191A (ko) 신질환치료제
KR880004809A (ko) 안정화 제약 조성물
NO902336D0 (no) Antispasmotiske midler.
DK0420121T3 (da) Antitumormiddel
KR870009997A (ko) 플루오로프탈이미드 화합물과 그의 제조방법 및 그를 함유하는 농원예용 살균제
KR920701120A (ko) 치환된 비시클로헵탄디온 유도체
KR870005968A (ko) 아미드 유도체 및 이를 함유하는 외용약제
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
KR900003177A (ko) 테트라시클릭계 우울증 치료제
DK0420224T3 (da) Anthihepatopatisk middel
KR890011835A (ko) 시스테인 유도체
KR900004706A (ko) Lo/co 억제 벤즈옥사졸론
KR890003718A (ko) N- 알킬벤젠 술포닐 카르바모일-5- 클로로이소티아졸 유도체 및 살미생물제
ZA93292B (en) Alkyl derivatives of trazodone
BR9303455A (pt) Emprego de compostos,dispositivos e agentes de combate de baratas,compostos e processo para sua preparacao
KR970700032A (ko) 항 hiv제(anti-hiv agent)

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application